We have developed a platform therapy with projected efficacy in several muiltibillion dollar markets. Details at https://chec-pr.com . At the "For Investors" tab note itemized year 01 operating budget at 1,380,000. No safety or stability concerns per initial contract research, ex vivo efficacy in humans, systemic efficacy in several animal models. Remainder to 3M will be used to expand Company (for example, new IP related to manipulation of protein repair mechanisms, collaborations with new peptide modification and delivery companies ). Led by internationally recognized team of scientists whose goal is to improve human health.
Ready to Ask For Funding for your company?
Post a Funding Request